CRNX- Crinetics Pharmaceuticals, Inc.

Name: Crinetics Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Crinetics Pharmaceuticals, Inc. (CRNX) has 13 insiders with recent SEC Form 4 filings, including 1 buy and 9 sells. CRNX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Struthers Richard Scott	426.8K	$15.99M	-
Dir	Wierenga Wendall	116.1K	$4.35M	-
Other	Pizzuti Dana	71.8K	$2.69M	-
Other	Kalofonos Isabel	55.0K	$2.06M	-
COO	Knight Jeff E.	55.0K	$2.06M	-

Activity

Buys and sells only

Transactions

10 filings · page 8

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Oct 17, 2022	Betz Stephen F.61	Chief Scientific Officer	Sell	3,126	$17.73	$55,423.98	-3.2%	+5.4%	+58.3%
Oct 3, 2022	Betz Stephen F.61	Chief Scientific Officer	Sell	3,126	$19.64	$61,394.64	-3.1%	-4.2%	+44.7%
Sep 15, 2022	Betz Stephen F.61	Chief Scientific Officer	Sell	4,168	$21.01	$87,569.68	-4.0%	-23.8%	+38.0%
Sep 7, 2022	Betz Stephen F.61	Chief Scientific Officer	Sell	1,042	$21.00	$21,883.77	-1.0%	-16.1%	-25.3%
Sep 1, 2022	Betz Stephen F.61	Chief Scientific Officer	Sell	3,126	$18.59	$58,112.34	-2.9%	-9.2%	-11.3%
Jul 26, 2022	Knight Jeff E.68	Chief Operating Officer	Sell	1,152	$20.70	$23,846.86	-18.9%	-17.3%	-8.2%
Jul 13, 2022	Fust Matthew K77	Director	Sale+OE	5,700	$20.96	$119,454.90	-31.3%	-20.8%	-6.0%
May 2, 2022	Betz Stephen F.61	Chief Scientific Officer	Sell	3,247	$20.10	$65,251.71	-2.9%	-10.3%	+2.9%
Apr 18, 2022	Betz Stephen F.61	Chief Scientific Officer	Sell	5,664	$25.81	$146,187.84	-4.9%	-15.4%	-26.5%
Apr 18, 2022	Perceptive Advisors LLC51	10% Owner	Buy	157,515	$22.22	$3,499,983.30	+3.1%	-15.4%	-26.5%

← PrevPage 8Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC